Dyne Therapeutics
Price & Volume
Stats
See more52W Range | $6.36-$25 |
Market Cap | $3.1B |
Shares Short | 19M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.69 |
News
See moreYahoo Finance • 4 days ago
This Biotech Was Quietly Bought Before a $58 Per Share Takeout
Yahoo Finance • 17 days ago
Dyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 (DM1)
Yahoo Finance • 17 days ago
Dyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)
Yahoo Finance • 24 days ago
Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing
About
CEO | Mr. John G. Cox M.B.A. |
CFO | Mr. Erick J. Lucera C.F.A., CPA |
Address | 1560 Trapelo Road, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 258 |
